Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXK7T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,698
Award facts
- Contract value 100% obligated
- $21,698.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,698.28 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a non-competitive award utilizing an existing contract vehicle. The products will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare operations worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements through competitive awards and established vehicle contracts. The delivery of Zepbound, a GLP-1 receptor agonist medication, reflects the company's role in supplying specialty pharmaceutical products to support the healthcare needs of the Defense Health Agency and other federal healthcare systems. This relatively short-duration delivery order exemplifies the operational flexibility of the DLA Troop Support Medical IDC in enabling rapid pharmaceutical procurement to meet immediate federal health requirements.
Quick answers
Who was awarded contract SPE2DR26FXK7T?
SPE2DR26FXK7T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FXK7T worth?
The government has obligated $21,698 on SPE2DR26FXK7T.
Is contract SPE2DR26FXK7T an order under another contract?
Yes. SPE2DR26FXK7T is a delivery order under SPE2DR25D6037, an indefinite delivery contract.
Was contract SPE2DR26FXK7T competed?
The extent of competition for SPE2DR26FXK7T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award